231 filings
Page 2 of 12
DFAN14A
xpehd9a sfj
1 Jul 21
Additional proxy materials by non-management
9:02am
8-K
t0y032 t20p4kbf8y
24 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
DFAN14A
rycyz5mh
17 Jun 21
Additional proxy materials by non-management
5:29pm
DEFA14A
664wk3gp
17 Jun 21
Additional proxy soliciting materials
12:00am
DFAN14A
7h0i1vl2
16 Jun 21
Additional proxy materials by non-management
4:30pm
DEFA14A
efx0 3a0w4qh
16 Jun 21
Additional proxy soliciting materials
7:34am
DFAN14A
ve0hji jk5p0veg5qje4
16 Jun 21
Additional proxy materials by non-management
7:08am
DEFA14A
l13yd60w40pca2ycf3jm
16 Jun 21
Additional proxy soliciting materials
6:47am
DEFA14A
ags5d2w7 tq1r6k
16 Jun 21
Additional proxy soliciting materials
6:44am
8-K
jnyne67tcsjs9ne
16 Jun 21
Form of Support Agreement
6:42am
8-K
3v2jzjoj
2 Jun 21
Other Events
8:39am
8-K
0dm0kh2lpjx7xk5t6
11 May 21
Kindred Biosciences Announces First Quarter 2021 Financial Results
4:10pm
DEFA14A
prh7ecb7z3ijgqj
29 Apr 21
Additional proxy soliciting materials
4:06pm
8-K
bqk8h 6i5sjkbvm
20 Apr 21
Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study
4:06pm
8-K
8ih27d13
16 Mar 21
Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results
4:03pm
8-K
dsk9cgx cu20me8
25 Feb 21
Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication
8:13am
8-K
8jkjpvggc63yws406
9 Feb 21
Kindred Biosciences Announces Two New Appointments to Board of Directors
9:08am